Dear colleagues and friends,
The 19th Congress of the IATDMCT, held for the first time in Italy, has just ended. During the days of the Congress (19-22 September 2021), the participants had the opportunity to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Therapeutic Drug Monitoring and Clinical Toxicology
We are confident that those present, as it happened to us, breathed the desire to meet again, discuss not only scientific topics but also to share experiences and lessons that this pandemic has taught us. We still carry all these emotions in our minds and hearts, combined with the happiness of meeting again people who in the previous months were just faces projected from a monitor.
There are so many people to thank for this wonderful journey that has come to an end, starting with Symposia, to the members of the LOC, to the Program Committee, to the reviewers of the abstracts, to all the people who have encouraged us in recent months not to give up, and to continue with our crazy idea of creating a hybrid congress! But above all, a special thank goes to all the participants (more than 400) who have decided to be present in Rome….You were the cornerstones of the success of the Rome congress! Last but not least, we also have to thank our overseas colleagues who wanted to be present virtually and in spirit despite the different hours of time difference!
The leitmotiv of the Congress was nobody is average to underline the need of individualized approaches to drug safety and efficacy through a continuous cross-talk between the laboratory and the clinicians. But, in the end, the lesson that we have learned from all of you is that IATDMCT is a true family-like friendly community!!!
Chair, IATDMCT 2021 Rome Congress